Consider alternating between abdomen and other sites like the outer thigh if abdominal issues persist
Ibrahim SS, Ibrahim RS, Arabi B, Brockmueller A, Shakibaei M, Busselberg D (2024) The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, et al
The practical implications of this difference extend to manufacturing, patent protection, dosing flexibility, and potentially even clinical outcomes
While clinical evidence 52,53 has indicated a possible elevated risk, causality has not been established